Maine Medicine Weekly Update - Maine Medicine Weekly Update: 12/24/2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
HAPPY HOLIDAYS FROM THE MMA
•  Enjoy The Holidays, Our Weekly Newsletter & Thank You For All You Do
COVID-19 CORNER
•  FDA Updates: Pfizer & Merck Oral Antivirals Authorized; Omicron & Monoclonal Antibodies
•  Maine CDC Updates & Guidance
•  Reminder: Everyone Ages 16 and Older Can Get a Booster Shot
•  US CDC Reduces Time for Health Care Workers to Isolate & Updates School Guidelines
•  English Study: Booster Shots Protect Against Omicron for About 10 Weeks
•  Patients Vaccinated for COVID-19 Have Shorter Hospital Stays Than Unvaccinated Patients
•  JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant
•  US Supreme Court to Take Up Federal COVID-19 Vaccine Rules
WHAT'S NOT COVID RELATED
•  CDC: Physicians Should Discuss Meds to Reduce HIV Risk
•  HHS: $48 Million Available to Increase the Public Health Workforce in Rural and Tribal Communities
•  MaineCare: Payment Cycle Reminder: Christmas and New Year's Day Holidays
IN THE NEWS
•  Medicine in the Media
•  Walgreens Pharmacy Hours Change: Call Ahead Before Picking Up Your Medication
MAINE MEDICAL ASSOCIATION JOB OPPORTUNITY
•  Maine Medical Education Trust (MMET) CME Program Coordinator
HEALTH COVERAGE
•  Open Enrollment For 2022 Individual Health Plans
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Governorís Opioid Response Seminar Webinar Series Continues (Jan 7)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Psychiatric Nurse Practitioner (PNP) - Greater Portland Health
•  Transformational OB/GYN or Maternal Fetal Medicine Physician leader

 

CDC: Physicians Should Discuss Meds to Reduce HIV Risk

The CDC has recommended that primary care physicians talk to all sexually active patients about prophylactic medications that can lessen HIV transmission risk. Pre-exposure prophylaxis, or PrEP, can be 99% effective in reducing risk.

The CDC has recommended that primary care physicians talk to all sexually active patients about prophylactic medications that can lessen HIV transmission risk. Pre-exposure prophylaxis, or PrEP, can be 99% effective in reducing risk.

Key Takeaways

The Centers for Disease Control and Prevention (CDC) is now recommending that physicians discuss prophylactic drugs that reduce the risk of HIV transmission (PrEP) with all of their patients who are sexually active.  

A brief discussion of a patient’s sexual history should be part of primary care and should guide physicians in discussing whether patients might need PrEP.

Many physicians skip taking a sexual history of patients—either because of their own or their patients’ discomfort. As a result, patients who could benefit from PrEP miss out on key HIV prevention measures.

verywellhealth.com – CDC: All Sexually Active Patients Should Know About HIV Prevention Drugs

US CDC – Pre-Exposure Prophylaxis (PrEP), Quick Guide: 2021 PrEP Update, Clinicians’ Quick Guide